Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Dejana Braithwaite, PhD, MS

    TitleAssociate Professor
    SchoolUCSF School of Medicine
    DepartmentEpidemiology & Biostatistics
    Address550 16th Street, 2nd Floor
    San Francisco CA 94158
    Phone415-514-8019

       Biography 
       Education and Training
      University of California, San FranciscoPostdoctoral StudiesGraduate Division
      University of Cambridge, EnglandPhD, Cancer EpidemiologyFaculty of Clinical Medicine2004
      University of LondonMSc, Public Health School of Medicine2000
      London Guildhall UniversityBSc, PsychologySchool of Health Sciences1998
       Awards and Honors
      American Cancer Society2012 - 2017Mentored Research Scholar
      Susan Komen for the Cure2012 - 2015Research Catalyst Award
      American Society for Preventive Oncology/Prevent Cancer Foundation2004 - 2006Cancer Prevention Fellow

       ORNG Applications 
       In The News
       NIH Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Epplein M, Bostick RM, Mu L, Ogino S, Braithwaite D, Kanetsky PA. Challenges and Opportunities in International Molecular Cancer Prevention Research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2613-7.
        View in: PubMed
      2. Swede H, Andemariam B, Gregorio DI, Jones BA, Braithwaite D, Rohan TE, Stevens RG. Adverse events in cancer patients with sickle cell trait or disease: case reports. Genet Med. 2014 Aug 21.
        View in: PubMed
      3. Hiatt RA, Porco TC, Liu F, Balke K, Balmain A, Barlow J, Braithwaite D, Diez-Roux AV, Kushi LH, Moasser MM, Werb Z, Windham GC, Rehkopf DH. A multilevel model of postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2078-92.
        View in: PubMed
      4. Izano M, Satariano WA, Tammemagi MC, Ragland D, Moore DH, Allen E, Naeim A, Sehl ME, Hiatt RA, Kerlikowske K, Sofrygin O, Braithwaite D. Long-term outcomes among African-American and white women with breast cancer: What is the impact of comorbidity? J Geriatr Oncol. 2014 Jul; 5(3):266-75.
        View in: PubMed
      5. Izano M, Satariano WA, Hiatt RA, Braithwaite D. The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study. BMJ Open. 2013; 3(10):e003232.
        View in: PubMed
      6. O'Meara ES, Zhu W, Hubbard RA, Braithwaite D, Kerlikowske K, Dittus KL, Geller B, Wernli KJ, Miglioretti DL. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67.
        View in: PubMed
      7. Wernli KJ, Kitahara CM, Tamers SL, Al-Temimi MH, Braithwaite D. Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1638-41.
        View in: PubMed
      8. Castillo-Trivino T, Braithwaite D, Bacchetti P, Waubant E. Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One. 2013; 8(7):e66308.
        View in: PubMed
      9. Dittus K, Geller B, Weaver DL, Kerlikowske K, Zhu W, Hubbard R, Braithwaite D, O'Meara ES, Miglioretti DL. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. J Gen Intern Med. 2013 Nov; 28(11):1454-62.
        View in: PubMed
      10. Braithwaite D, Mandelblatt JS, Kerlikowske K. To screen or not to screen older women for breast cancer: a conundrum. Future Oncol. 2013 Jun; 9(6):763-6.
        View in: PubMed
      11. Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, Wernli KJ, Miglioretti DL, O'Meara ES. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16.
        View in: PubMed
      12. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 6; 105(5):334-41.
        View in: PubMed
      13. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
        View in: PubMed
      14. Braithwaite D, Boffetta P, Rebbeck TR, Meyskens F. Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group. Cancer Epidemiol Biomarkers Prev. 2012 Sep; 21(9):1606-10.
        View in: PubMed
      15. Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ. Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
        View in: PubMed
      16. Rehkopf DH, Laraia BA, Segal M, Braithwaite D, Epel E. The relative importance of predictors of body mass index change, overweight and obesity in adolescent girls. Int J Pediatr Obes. 2011 Jun; 6(2-2):e233-42.
        View in: PubMed
      17. Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A, Melisko M, Esserman L, Weltzien EK, Caan BJ. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 Oct 6; 102(19):1468-77.
        View in: PubMed
      18. Glasspool DW, Oettinger A, Braithwaite D, Fox J. Interactive decision support for risk management: a qualitative evaluation in cancer genetic counselling sessions. J Cancer Educ. 2010 Sep; 25(3):312-6.
        View in: PubMed
      19. Braithwaite D, Wernli KJ, Anton-Culver H, Engstrom P, Greenberg ER, Meyskens F. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1665-7.
        View in: PubMed
      20. Joseph G, Beattie MS, Lee R, Braithwaite D, Wilcox C, Metrikin M, Lamvik K, Luce J. Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT). J Genet Couns. 2010 Oct; 19(5):447-62.
        View in: PubMed
      21. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 1; 124(5):1213-9.
        View in: PubMed
      22. Braithwaite D, Moore DH, Lustig RH, Epel ES, Ong KK, Rehkopf DH, Wang MC, Miller SM, Hiatt RA. Socioeconomic status in relation to early menarche among black and white girls. Cancer Causes Control. 2009 Jul; 20(5):713-20.
        View in: PubMed
      23. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9.
        View in: PubMed
      24. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. Fam Cancer. 2006; 5(1):61-75.
        View in: PubMed
      25. Braithwaite D, Sutton S, Mackay J, Stein J, Emery J. Development of a risk assessment tool for women with a family history of breast cancer. Cancer Detect Prev. 2005; 29(5):433-9.
        View in: PubMed
      26. Walter FM, Emery J, Braithwaite D, Marteau TM. Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med. 2004 Nov-Dec; 2(6):583-94.
        View in: PubMed
      27. Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S. Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2004 Jan 21; 96(2):122-33.
        View in: PubMed
      28. Braithwaite D, Emery J, De Lusignan S, Sutton S. Using the Internet to conduct surveys of health professionals: a valid alternative? Fam Pract. 2003 Oct; 20(5):545-51.
        View in: PubMed
      29. Braithwaite D, Sutton S, Smithson WH, Emery J. Internet-based risk assessment and decision support for the management of familial cancer in primary care: a survey of GPs' attitudes and intentions. Fam Pract. 2002 Dec; 19(6):587-90.
        View in: PubMed
      30. Braithwaite D, Sutton S, Steggles N . Intention to participate in predictive genetic testing for hereditary cancer: the role of attitude toward uncertainty. Psychology and Health. 2002; 6(17):761-772.
      Dejana's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP